Cipla Ltd strengthened its play in beauty and personal care

$CIPLA expanding its consumer health business segment. Cipla announced additional investment in Achira, strengthening its strategic partnerships. Sanofi and Cipla announced an exclusive distribution partnership to expand reach of CNS portfolio in India, enhancing the company's presence in the specialty pharmaceutical market. Cipla strengthened its fight against antimicrobial resistance (AMR), securing approval to introduce ZEMDRI® (plazomicin) injection in India, demonstrating commitment to addressing critical healthcare challenges.